The following equity analysts have regular coverage on Faron Pharmaceuticals on their own initiative. The list may be incomplete. Faron is not responsible for their views.
Carnegie, Klas Palin, klas.palin@carnegie.se
Redeye, Kevin Sule, kevin.sule@redeye.se
Inderes, Antti Siltanen, antti.siltanen@inderes.fi
H.C.WAINWRIGHT&CO, Patrick R, Trucchio, ptrucchio@hcwresearch.com
Peel Hunt, Miles Dixon, miles.dixon@peelhunt.com
Kepler Chevreaux, Jon Berggren, jberggren@keplercheuvreux.com
Panmure Gordon, Julie Simmonds, julie.simmonds@panmure.com
The information above is disclosed in accordance with Rule 26 of the AIM Rules for Companies.